Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $168.7 million as of June 26, 2026. Its market cap has increased by 47.77% in one year.
Market Cap
168.70M
Enterprise Value
121.81M
1-Year Change
47.77%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $168.70M, a decrease of -53.58%. That is a compound annual growth rate of -10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 168.70M | -17.78% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 182.48M |
| OnKure Therapeutics | 181.78M |
| Pyxis Oncology | 175.49M |
| Acumen Pharmaceuticals | 170.46M |
| Innate Pharma | 168.65M |
| Caribou Biosciences | 166.62M |
| YD Bio | 165.25M |
| Kazia Therapeutics | 162.49M |